DELAYED PLATELET ENGRAFTMENT

This adverse event was reported 4 times

DELAYED PLATELET ENGRAFTMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EXAGAMGLOGENE AUTOTEMCEL 1 0.0200
1 ERYTHROPOIETIN 1 0.0000
2 MELPHALAN HYDROCHLORIDE 1 0.0000
3 CARFILZOMIB 1 0.0000
4 FILGRASTIM 1 0.0000
5 CYCLOPHOSPHAMIDE FOR INJECTION 3 0.0000
6 CYCLOPHOSPHAMIDE 3 0.0000
7 TACROLIMUS OINTMENT 0.1% 2 0.0000
8 TACROLIMUS EXTENDED-RELEASE CAPSULES 2 0.0000
9 MYCOPHENOLATE MOFETIL 2 0.0000
See all drugs enriched for association with DELAYED PLATELET ENGRAFTMENT

DELAYED PLATELET ENGRAFTMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 1 0.0000
1 Alkylating Drug [EPC] 3 0.0000
2 Proteasome Inhibitor [EPC] 1 0.0000
3 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
4 Leukocyte Growth Factor [EPC] 1 0.0000
5 Platinum-based Drug [EPC] 1 0.0000
6 Thalidomide Analog [EPC] 1 0.0000
7 Corticosteroid [EPC] 2 0.0000
See all drug classes enriched for association with DELAYED PLATELET ENGRAFTMENT